BioSpace News Archive

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2023 financial results after market close on Tuesday, May 2, 2023.

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five upcoming investor conferences in May.

Cardiac Dimensions today announced that its Carillon Mitral Contour System ® has received certification under Regulation (EU) 2017/745 (“MDR”).

EnChroma and the University of North Carolina at Chapel Hill’s Department of Health Sciences announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient to borrow from the UNC Health Sciences Library and the UNC Davis Library to help them better navigate schoolwork that utilizes colors.

bioAffinity Technologies, Inc. will present at the Cleveland Clinic’s invitation-only Advances in Early Lung Cancer Detection annual symposium in Cleveland, Ohio, on April 27, 2023.

UroGen Pharma Ltd. today announced that it will participate in a fireside chat at the upcoming H.C. Wainwright BioConnect Conference on May 2, 2023 at 10:00 AM ET.

Corner Therapeutics today announced the appointment of Rick Malley, M.D., to their Scientific Advisory Board.

Halberd Corporation. The first quarter 2023 continued this extraordinarily groundbreaking path, packed with new accomplishments.

Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET ® (U.S.)/MAVIRET ® (ex-U.S.) (Glecaprevir/Pibrentasvir) to OMERS Life Sciences for $200 Million.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 9:20 a.m. PT/12:20 p.m. ET.